RARB and acute promyelocytic leukemia: The same group reported a second study on 29 APL patients and analyzed the clinicopathologic and prognostic impact of the following genes: p15, p16, RARB, estrogen receptor (ER), E cadherin (E-CAD), p73, caspase 8 (CASP8), VHL, MGMT (52).